Other views, page-17

cupla things

firstly dbs is an immediate and effective amelioration and as @Osgood reflects it does not alter the long-term course of the PD progression

whereas the small trial clearly shows a significant-enough tail away of the effect of PD on some patients from some (80) samples

so these are completely different lenses to view cause and effect of two entirely different treatments

it's like being in a bumper car at the circus versus riding the Ghan ...one is instant crash bang yerr done the other is an imperceptible take off and long run

PD patients are normal people with PD (sorry, it sounds dumb even when i type it!) so the expectations are greater, the perception is to see a significant instance like DBS is like a thirst that needs to be quenched

we can think of the two in opposing directions dbs is a pop leading to a long hiss and NTcell implants are the opposite end of that effect

that's clearly another singular thing that needed to be marketed (effect v affect)

.....and we need a bigger trial (which would demonstrate this exact difference, as subtle as it appears currently)

imho